维康药业
(300878)
| 流通市值：13.78亿 | | | 总市值：25.66亿 |
| 流通股本：7774.25万 | | | 总股本：1.45亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 199,953,044.93 | 519,621,071.15 | 432,001,715.94 | 316,438,664.65 |
| 营业收入 | 199,953,044.93 | 519,621,071.15 | 432,001,715.94 | 316,438,664.65 |
| 二、营业总成本 | 173,888,443.65 | 560,065,209.92 | 359,422,532.3 | 263,848,028.57 |
| 营业成本 | 102,127,742.39 | 257,763,389.96 | 180,816,722.91 | 140,667,973.07 |
| 税金及附加 | 4,721,783.8 | 2,813,582.74 | 1,293,215.85 | 680,794.69 |
| 销售费用 | 52,336,889.43 | 208,186,400.97 | 123,568,303.39 | 83,679,867.92 |
| 管理费用 | 10,773,840.43 | 40,941,584.86 | 28,653,331.44 | 18,766,830.54 |
| 研发费用 | 2,971,220.93 | 42,798,186.43 | 19,866,229.36 | 16,484,131.27 |
| 财务费用 | 956,966.67 | 7,562,064.96 | 5,224,729.35 | 3,568,431.08 |
| 其中:利息费用 | 1,242,219.45 | 9,449,684.78 | 6,115,600.8 | 4,035,928.74 |
| 其中:利息收入 | 616,539.48 | 1,978,923.07 | 1,400,102.03 | 951,674.72 |
| 加:公允价值变动收益 | 2,192,798.4 | 4,564,629.39 | - | - |
| 加:投资收益 | 1,245,053.9 | 13,867,915.07 | 7,203,488.32 | 7,203,488.32 |
| 资产处置收益 | -30,532.26 | -5,821.95 | 12,429.88 | 12,429.88 |
| 资产减值损失(新) | -34,612.01 | -736,974.52 | -125,865.55 | -69,224.03 |
| 信用减值损失(新) | -4,978,010.08 | 11,461,123.46 | 9,266,986.46 | 11,143,664.02 |
| 其他收益 | 2,174,772.84 | 10,279,773.63 | 5,260,280.75 | 3,012,092.54 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 26,634,072.07 | -1,013,493.69 | 94,196,503.5 | 73,893,086.81 |
| 加:营业外收入 | 35,801.23 | 518,785.49 | 53,562.01 | 49,963.57 |
| 减:营业外支出 | 318,760.97 | 5,291,187.6 | 5,161,588.04 | 579,283.92 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 26,351,112.33 | -5,785,895.8 | 89,088,477.47 | 73,363,766.46 |
| 减:所得税费用 | 1,961,788.37 | 398,592.69 | 18,215,148.53 | 7,838,244.11 |
| 六、净利润 | 24,389,323.96 | -6,184,488.49 | 70,873,328.94 | 65,525,522.35 |
| 持续经营净利润 | 24,389,323.96 | -6,184,488.49 | 70,873,328.94 | 65,525,522.35 |
| 归属于母公司股东的净利润 | 24,334,978.24 | -8,038,557.83 | 69,350,633.99 | 64,620,653.89 |
| 少数股东损益 | 54,345.72 | 1,854,069.34 | 1,522,694.95 | 904,868.46 |
| (一)基本每股收益 | 0.17 | -0.06 | 0.48 | 0.45 |
| (二)稀释每股收益 | 0.17 | -0.06 | 0.48 | 0.45 |
| 九、综合收益总额 | 24,389,323.96 | -6,184,488.49 | 70,873,328.94 | 65,525,522.35 |
| 归属于母公司股东的综合收益总额 | 24,334,978.24 | -8,038,557.83 | 69,350,633.99 | 64,620,653.89 |
| 归属于少数股东的综合收益总额 | 54,345.72 | 1,854,069.34 | 1,522,694.95 | 904,868.46 |
| 公告日期 | 2024-04-29 | 2024-04-29 | 2023-10-30 | 2023-08-29 |
| 审计意见(境内) | | 保留意见 | | |